Quantcast
Don't Miss

Neuralstem wants trials on spinal patients

Biotech company Neuralstem Inc. said Wednesday it wants to test its stem cell treatment on patients with spinal cord injuries that have caused paralysis. The Rockville-based company filed an application with the U.S. Food and Drug Administration seeking approval to start a new clinical trial, hopefully by the end of the year. The spinal cord ...

Print, Digital & Mobile

Monthly Autorenew
$9.99
(special offer!)

----------
3 Months
$84.00

----------
6 Months
$162.00

----------
1 Year
$269.00


Digital & Mobile Only

1 Year
$169.00

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

 
Scroll To Top